Simon Moroney, co-founder and CEO of Munich-based biotech MorphoSys AG has made clear his plans to retire by June 2020. He has been at the helm of MorphoSys since its inception 27 years ago, and believes that the company has now reached a turning point, becoming more competitive and controlling its own destiny, which creates an opportune point to hand the reins to someone that can lead the company through its next stage of development.
In an exclusive interview with Scrip, New Zealand-born Moroney said he felt it was vital to ensure the company was...






